Patent Assignment
Reel/Frame 059717/0340
Assignment of Assignor's Interest
Recorded: 2022-04-14
Pages: 2
Assignor
RALPH, DAVID A.
Executed: 2019-10-18
Assignee
NAVIDEA BIOPHARMACEUTICALS, INC.
4995 BRADENTON AVENUE, SUITE 240, DUBLIN, OHIO, 43017
Covered Property
(1)
Compositions and Related Methods for Blocking Off-Target Localization of Mannosylated Dextrans and Other CD206 Ligands
Application:
17/039,409 →
Publication:
US 2021/0145989
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 6, 2023
From: RALPH, DAVID A.; ARNOLD, JEFFREY
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 062892/0840 →
Security Interest
Sep 26, 2024
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 068711/0393 →
Corrective Assignment to Correct the Receiving Party Information Previously Recorded on Reel 68711 Frame 393. Assignor(S) Hereby Confirms the Security Agreement.
Sep 27, 2024
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: SCOTT, JOHN KIM, JR.
Reel/Frame 069165/0332 →
Us Bankruptcy Court Sale Order Dated Jan. 30, 2026 to Release Security Interest Recorded at 069165 / 0332
Feb 12, 2026
From: SCOTT, JOHN KIM, JR.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 074831/0644 →